releases: https://delauro.house.gov/media-center/press-releases/delauro-opposes-bomb-sales-israel
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://delauro.house.gov/media-center/press-releases/delauro-opposes-bomb-sales-israel | DeLauro Opposes Bomb Sales to Israel | 2026-09-17 | 2026 | 2026-09 | Democrat | House | CT | Rosa L. DeLauro | D000216 | delauro.house.gov | delauro | https://delauro.house.gov/media-center/press-releases | scraper | Today, Congresswoman Rosa DeLauro (CT-03) expressed her strong opposition to an announcement from the Trump administration that they would authorize the sale of $2.8 billion in arms sales to Israel. House Foreign Affairs Committee Ranking Member Gregory Meeks placed a hold on the sale yesterday: “40,000 of the deadliest bombs in the American arsenal are now set to be handed over to the Netanyahu government which has shown time and time again it has little regard for civilian life. These are the same bombs the Biden Administration refused to send because of the risk of mass civilian casualties. “I am opposed to this sale. Israel’s war in Gaza and its operations in Southern Lebanon have shown they cannot prosecute these wars in a way that spares civilian life. The sale of these bombs risk worsening an already out of hand humanitarian crisis. “I am also concerned about what this sale means for our own military readiness. Sending 40,000 of these bombs depletes already strained American stockpiles. “These weapons must not be sent.” Congresswoman DeLauro, Ranking Member of the House Appropriations Committee, is a leader in Congress in calling for a major surge in humanitarian aid to Gaza and in advocating for a two-state solution that provides long term security for the Israeli and Palestinian people. | 1 | 2026-09-18T09:27:43Z | 2026-09-18T09:29:09Z |